Featured Posters & Presentations
Lyfgenia
Successful plerixafor-mediated mobilization, apheresis, and lentiviral vector transduction of hematopoietic stem cells in patients with severe sickle cell disease.
Authors: Tisdale JF.
Lyfgenia
Longer-term follow-up on the first patients with severe hemoglobinopathies treated with LentiGlobin gene therapy.
Authors: Cavazzana M.
Lyfgenia
Interim results from a Phase 1/2 clinical study of LentiGlobin gene therapy for severe sickle cell disease.
Authors: Kanter J.